Glencoe, IL, United States of America

David G Rosenbaum

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 2.7

ph-index = 4

Forward Citations = 54(Granted Patents)


Company Filing History:


Years Active: 2006-2022

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: David G. Rosenbaum: Innovator in In Vivo Imaging Technologies

Introduction

David G. Rosenbaum is a notable inventor located in Glencoe, Illinois, renowned for his contributions to the field of medical imaging. Over his career, he has been awarded four patents, showcasing his innovative approach to technology in healthcare.

Latest Patents

Among his most recent inventions is the OCT-IVUS catheter for concurrent luminal imaging. This groundbreaking apparatus is designed for in vivo imaging and combines an Optical Coherence Tomography (OCT) system with an Intravascular Ultrasound (IVUS) system. This dual functionality is particularly significant for imaging luminal systems, which include various vasculature systems, namely cardiac vasculature, peripheral vasculature, and neural vasculature.

Career Highlights

Throughout his career, David has worked for leading companies in the biomedical sector, including Advanced Bio Prosthetic Surfaces, Ltd. and Volcano Corporation. These positions have allowed him to apply his innovative ideas and advance medical technology significantly.

Collaborations

David has collaborated with prominent professionals in his field, including Christopher E. Banas and Paul Castella. These partnerships have facilitated the successful development of his inventions and have further contributed to advancements in medical imaging technologies.

Conclusion

David G. Rosenbaum continues to be a pivotal figure in the field of medical innovation. His work with the OCT-IVUS catheter exemplifies a commitment to enhancing in vivo imaging, thus improving diagnostic capabilities within the medical community. With his ongoing contributions, he is set to influence the future of healthcare technology significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…